Tag: coronary artery bypass graft

New Light Cast on Type-2 MI Aims to Sharpen Diagnosis, Therapy

The hospital and post-discharge course of patients diagnosed with type-2 myocardial infarction (MI), triggered when myocardial oxygen demand outstrips supply, differs in telling ways from...

Ischemia Not Linked to 10-Year Mortality, CABG Benefit

The presence of ischemia on stress testing should not be used to refer patients with ischemic cardiomyopathy for coronary artery bypass graft (CABG) surgery, a...

No Effect on Elective Heart Surgery Result in Seniors

NEW YORK (Reuters Health) – Among older adults who underwent elective coronary and aortic valve surgery during influenza seasons, “no consistent associations” were seen between...

Sex Differences Found in Post-CABG Mortality

A new study shows sex differences in mortality rates among patients undergoing coronary artery bypass grafting (CABG). The researchers found that 7 years after a...

The ‘Grubby’ Affair of the EXCEL Trial and the European Guidelines

“I disapprove of what you say, but I will defend to the death your right to say it.” The choice of the secretary general of...

Levosimendan Hints at Benefit in Unusual Form of Heart Failure

An inotropic and vasodilating drug with few clinical-trial victories in heart failure (HF) or other low-cardiac-output conditions showed some limited success in a specific subtype...

Female Benefit With CABG Vanishes by 10 Years

The beneficial effect on all-cause mortality of coronary artery bypass grafting surgery (CABG) observed at 4 and 5 years in women with complex coronary disease...

PCI Comes Up Short for Most, but Not All Multivessel CTOs

Percutaneous coronary intervention (PCI) is associated with greater risks for long-term adverse cardiovascular events than surgery in patients with chronic total occlusion (CTO) and multivessel...

SCAI Weighs In on PCI at Ambulatory Surgical Centers

The Society for Cardiovascular Angiography and Interventions (SCAI) has issued a position paper on percutaneous coronary intervention (PCI) in ambulatory surgical centers (ASCs) that makes...

Icosapent Ethyl Cuts Revascularization: Latest From REDUCE-IT

A new analysis from the REDUCE-IT trial has shown that the high-strength eicosapentaenoic acid product icosapent ethyl (Vascepa, Amarin) reduced the number of revascularization procedures...

Radial Arteries Show CABG Survival Advantage Over Saphenous Veins

Coronary bypass surgery patients who received a radial artery as their second bypass conduit had significantly better 10-year survival than did patients who received a...

Unusually Long-Term PCI vs CABG Data in LMCA

It is a truth universally acknowledged that a trial comparing interventional strategies for left-main coronary artery (LMCA) disease launched more than a decade ago may...